Condition
Neisseria Gonorrhea
Total Trials
3
Recruiting
1
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
P 1 (1)
Trial Status
Recruiting1
Not Yet Recruiting1
Active Not Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07758972Phase 1RecruitingPrimary
Safety and Immunogenicity Study of a Multivalent Gonorrhoea Vaccine
NCT07671014Not Yet Recruiting
Metagenomic Analysis of the Pharynx in High Risk Partners
NCT06570733Active Not RecruitingPrimary
Acceptability Research on Integrated Point of Care Sexually Transmitted Infection (STI) Testing and Expedited Partner Therapy (EPT)
Showing all 3 trials